Literature DB >> 28164030

The dilemma of diagnostic testing for Prader-Willi syndrome.

Arabella Smith1, Dorothy Hung2.   

Abstract

Although Prader-Willi syndrome (PWS) is a well-described clinical dysmorphic syndrome, DNA testing is required for a definitive diagnosis. A definitive diagnosis can be made in approximately 99% of cases using DNA testing; there are a number of DNA tests that can be used for this purpose, although there is no set standard algorithm of testing. The dilemma arises because of the complex genetic mechanisms at the basis of PWS, which need to be elucidated. To establish the molecular mechanism with a complete work up, involves at least 2 tests. Here we discuss the commonly used tests currently available and suggest a cost-effective approach to diagnostic testing.

Entities:  

Keywords:  Cytogenetics; chromosome microarray; methylation

Year:  2017        PMID: 28164030      PMCID: PMC5253259          DOI: 10.21037/tp.2016.07.04

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


  49 in total

1.  Birth prevalence of Prader-Willi syndrome in Australia.

Authors:  A Smith; J Egan; G Ridley; E Haan; P Montgomery; K Williams; E Elliott
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

Review 2.  Non-coding RNAs: hope or hype?

Authors:  Alexander Hüttenhofer; Peter Schattner; Norbert Polacek
Journal:  Trends Genet       Date:  2005-05       Impact factor: 11.639

3.  Deletion of 15q11.2(BP1-BP2) region: further evidence for lack of phenotypic specificity in a pediatric population.

Authors:  Bita Hashemi; Anne Bassett; David Chitayat; Karen Chong; Mark Feldman; Janine Flanagan; Sharan Goobie; Anne Kawamura; Chelsea Lowther; Chitra Prasad; Victoria Siu; Joyce So; Sharon Tung; Marsha Speevak; Dimitri J Stavropoulos; Melissa T Carter
Journal:  Am J Med Genet A       Date:  2015-05-06       Impact factor: 2.802

4.  The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.

Authors:  M Gunay-Aygun; S Schwartz; S Heeger; M A O'Riordan; S B Cassidy
Journal:  Pediatrics       Date:  2001-11       Impact factor: 7.124

5.  Syndromal obesity due to paternal duplication 6(q24.3-q27).

Authors:  A Smith; A Jauch; H Slater; L Robson; T Sandanam
Journal:  Am J Med Genet       Date:  1999-05-21

6.  Disruption of the bipartite imprinting center in a family with Angelman syndrome.

Authors:  K Buiting; A Barnicoat; C Lich; M Pembrey; S Malcolm; B Horsthemke
Journal:  Am J Hum Genet       Date:  2001-03-23       Impact factor: 11.025

7.  Supernumerary marker chromosomes (SMC) and uniparental disomy (UPD): coincidence or consequence?

Authors:  D Kotzot
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

Review 8.  Mouse models of Prader-Willi Syndrome: a systematic review.

Authors:  Sandrina Bervini; Herbert Herzog
Journal:  Front Neuroendocrinol       Date:  2013-02-04       Impact factor: 8.606

9.  Clinical and molecular analysis of five inv dup(15) patients.

Authors:  W P Robinson; F Binkert; R Giné; C Vazquez; W Müller; W Rosenkranz; A Schinzel
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

Review 10.  Uniparental disomy in Robertsonian translocations: strategies for uniparental disomy testing.

Authors:  Moh-Ying Yip
Journal:  Transl Pediatr       Date:  2014-04
View more
  7 in total

1.  Prader Willi Syndrome - A Common Epigenetic Cause of Syndromic Obesity.

Authors:  Neerja Gupta; Vandana Jain
Journal:  Indian J Pediatr       Date:  2017-10-02       Impact factor: 1.967

Review 2.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

3.  A rapid and accurate methylation-sensitive high-resolution melting analysis assay for the diagnosis of Prader Willi and Angelman patients.

Authors:  Igor Ribeiro Ferreira; Wilton Darleans Dos Santos Cunha; Leonardo Henrique Ferreira Gomes; Hiago Azevedo Cintra; Letícia Lopes Cabral Guimarães Fonseca; Elenice Ferreira Bastos; Juan Clinton Llerena; Zilton Farias Meira de Vasconcelos; Letícia da Cunha Guida
Journal:  Mol Genet Genomic Med       Date:  2019-04-29       Impact factor: 2.183

4.  Genetic testing for Prader-Willi syndrome and Angelman syndrome in the clinical practice of Guangdong Province, China.

Authors:  Chang Liu; Xiangzhong Zhang; Jicheng Wang; Yan Zhang; Anshi Wang; Jian Lu; Yanlin Huang; Shu Liu; Jing Wu; Li Du; Jie Yang; Hongke Ding; Ling Liu; Xin Zhao; Aihua Yin
Journal:  Mol Cytogenet       Date:  2019-02-18       Impact factor: 2.009

Review 5.  Genotype-Phenotype Relationships and Endocrine Findings in Prader-Willi Syndrome.

Authors:  Régis Afonso Costa; Igor Ribeiro Ferreira; Hiago Azevedo Cintra; Leonardo Henrique Ferreira Gomes; Letícia da Cunha Guida
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-13       Impact factor: 5.555

6.  A Novel Mutation in the Myosin Binding Protein C Gene in a Prader-Willi Syndrome Pedigree.

Authors:  Xiao-Qun Liu; Man Luo; Qi Liu; Guo-Can Yang
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 3.060

7.  Clinical Utility of Methylation-Specific Multiplex Ligation-Dependent Probe Amplification for the Diagnosis of Prader-Willi Syndrome and Angelman Syndrome.

Authors:  Boram Kim; Yongsook Park; Sung Im Cho; Man Jin Kim; Jong-Hee Chae; Ji Yeon Kim; Moon-Woo Seong; Sung Sup Park
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.